Status:
COMPLETED
Effects of Budesonide & Budesonide/Formoterol on Smoking Asthmatic Subjects
Lead Sponsor:
Laval University
Collaborating Sponsors:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18-45 years
Phase:
PHASE3
Brief Summary
A reduced response to inhaled corticosteroids (ICS) has been reported in smoking compared to non-smoking asthmatic patients. However, the comparative response to other currently prescribed medications...
Eligibility Criteria
Inclusion
- Asthmatic non-smokers or ex-smokers (less than 10 pack/years)
- Asthmatic smokers (more than 5 cigarettes a day and more than 5 pack/years
- FEV1 greater than 70%
- No more than 3 doses of rescue medication (bronchodilator) per day
Exclusion
- Mentally or legally incapacitated thus preventing informed consent from being obtained
- Other pulmonary disorder
- History of upper respiratory tract infection in the last month
- Pregnant or lactating women
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00691951
Last Update
October 21 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital du Sacré-Coeur de Montreal
Montreal, Quebec, Canada, H4J 1C5
2
Laval Hospital
Québec, Quebec, Canada, G1V 4G5